Optas LLC Invests $173,000 in Haleon plc (NYSE:HLN)

Optas LLC bought a new stake in Haleon plc (NYSE:HLN) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 18,097 shares of the company’s stock, valued at approximately $173,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Fortitude Family Office LLC acquired a new stake in Haleon during the 3rd quarter valued at approximately $28,000. Versant Capital Management Inc lifted its position in Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock valued at $34,000 after purchasing an additional 3,348 shares during the period. Geneos Wealth Management Inc. purchased a new stake in Haleon in the fourth quarter valued at $35,000. Toronto Dominion Bank grew its position in Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after purchasing an additional 3,470 shares during the period. Finally, Spire Wealth Management purchased a new position in shares of Haleon during the 4th quarter valued at about $39,000. Institutional investors and hedge funds own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on HLN shares. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $10.95.

Haleon Stock Performance

NYSE HLN opened at $9.54 on Wednesday. The stock has a market capitalization of $43.16 billion, a price-to-earnings ratio of 28.04, a PEG ratio of 2.69 and a beta of 0.28. The stock has a 50-day moving average of $9.54 and a 200 day moving average of $9.77. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon plc has a twelve month low of $7.89 and a twelve month high of $10.80.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.